DRUG fundamentals
The current financial position of Bright Minds Biosciences Inc.
Total assets of DRUG for Q1 25 is 40.58 M USD, 799.48% more than the previous Q4 24. And total liabilities decreased by 5.42% in Q1 25 to 397.2 k USD.
Q1 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
0.00
11.00 M
22.00 M
33.00 M
44.00 M
Total assets
Total liabilities
Currency: USD
Q1 '20
Dec 2019
Q1 '21
Dec 2020
Q2 '21
Mar 2021
Q3 '21
Jun 2021
Q4 '21
Sep 2021
Q1 '22
Dec 2021
Q2 '22
Mar 2022
Q3 '22
Jun 2022
Q4 '22
Sep 2022
Q1 '23
Dec 2022
Q2 '23
Mar 2023
Q3 '23
Jun 2023
Q4 '23
Sep 2023
Q1 '24
Dec 2023
Q2 '24
Mar 2024
Q3 '24
Jun 2024
Q4 '24
Sep 2024
Q1 '25
Dec 2024
Total assetsYoY growth
7.38 M
−21.45%
6.38 M
−6.80%
5.06 M
−42.02%
5.20 M
−39.01%
4.82 M
−34.71%
4.59 M
−28.13%
4.51 M
−10.90%
40.58 M
+680.97%
Total liabilitiesYoY growth
769.36 K
−4.07%
554.34 K
+85.28%
206.74 K
−81.48%
644.46 K
+49.94%
624.36 K
−18.85%
130.52 K
−76.45%
419.97 K
+103.14%
397.20 K
−38.37%
Total equityYoY growth
6.62 M
−23.08%
5.83 M
−11.00%
4.86 M
−36.24%
4.55 M
−43.74%
4.20 M
−36.55%
4.46 M
−23.53%
4.09 M
−15.76%
40.18 M
+782.81%
7.38 M
6.38 M
5.06 M
5.20 M
4.82 M
4.59 M
4.51 M
40.58 M